Identification of circulating tumor cells with EML4-ALK translocation using fluorescence in situ hybridization in advanced ALK-positive patients with lung cancer

Ítems similars

• Identification of circulating tumor cells with EML4-ALK translocation using fluorescence in situ hybridization in advanced ALK-positive patients with lung cancer
  per: Kim, Young Hun, et al.
  Publicat: (2018)
• Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer
  per: Pekar-Zlotin, Marina, et al.
  Publicat: (2015)
• Characterization of Robertsonian translocations by using fluorescence in situ hybridization.
  per: Wolff, D J, et al.
  Publicat: (1992)
• Fluorescence In Situ Hybridization–Based Karyotyping of Soybean Translocation Lines
  per: Findley, Seth D., et al.
  Publicat: (2011)
• Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation
  per: Kim, Hyeong Ryul, et al.
  Publicat: (2013)